Skip to main content
. Author manuscript; available in PMC: 2017 Sep 7.
Published in final edited form as: Vascul Pharmacol. 2015 Aug 22;74:103–113. doi: 10.1016/j.vph.2015.08.014

Fig. 7.

Fig. 7

Treatment with diminazene reduced the accumulation of macrophages in the vulnerable plaques. Quantification for CD68 (macrophage marker) immunostaining in: LSS-induced plaques (A); OSS-induced plaques (B) and aortic sinus plaques (C) of diminazene- and vehicle-treated ApoE−/−mice. n.s.: non-significant and *p < 0.05 (Mann–Whitney nonparametric test). Data were expressed as mean ± SEM. Representative microphotographs (D).